Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Dermatology Reports|February 18, 2025
Real-world experience with vismodegib and sonidegib in advanced basal cell carcinoma: a multicenter Italian studyMario Valenti, Sara Di Giulio, Andrea Carugno, et al.
Italian Journal of Dermatology and Venereology|January 10, 2022
Early predictors of psoriatic arthritis: a Delphi-based consensus from Italian dermatology centersFrancesco Messina, Mario Valenti, Piergiorgio Malagoli, et al.
Dermatology and Therapy|July 25, 2026
JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort StudyPaola Facheris, Luigi Gargiulo, Luciano Ibba, et al.
The Journal of Dermatological Treatment|June 8, 2023
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centersDiego Orsini, Luigi Gargiulo, Luciano Ibba, et al.
Dermatology (Basel, Switzerland)|May 6, 2020
Disease Severity Is Associated with Alexithymia in Patients with Atopic DermatitisAndrea Chiricozzi, Maria Esposito, Paolo Gisondi, et al.
The Journal of Dermatology|January 31, 2024
Effectiveness of ixekizumab for the treatment of moderate-to-severe plaque psoriasis with involvement of difficult-to-treat areas: A 52-week multicenter retrospective studyMario Valenti, Luigi Gargiulo, Luciano Ibba, et al.
Acta Dermato-Venereologica|October 1, 2021
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective StudyRiccardo G Borroni, Piergiorgio Malagoli, Luigi Gargiulo, et al.
Melanoma Research|October 3, 2024
Anorectal melanoma: systematic review of the current literature of an aggressive type of melanomaGiovanni Paolino, Antonio Podo Brunetti, Carolina De Rosa, et al.
Clinical and Experimental Dermatology|April 2, 2025
Potential Role of Leptin in JAK2 Inhibitor-Associated Weight Gain: A Monocentric Retrospective StudyLuciano Ibba, Luigi Gargiulo, Matteo Bianco, et al.
Dermatology and Therapy|March 28, 2026
Real-World Effectiveness and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Italian Study Focusing on Head and Neck InvolvementLuigi Gargiulo, Luciano Ibba, Matteo Bianco, et al.
Pageof 8